Platelet-derived microparticles in patients with arteriosclerosis obliterans: Enhancement of high shear-induced microparticle generation by cytokines

Thrombosis Research

Volumn 98, Issue 4, 2000, Pages 257-268

  Nomura, Shosaku ^a   Imamura, Atsushi ^a   Okuno, Masashi ^a   Kamiyama, Yasuo ^a   Fujimura, Yoshihiro ^b   Ikeda, Yasuo ^c   Fukuhara, Shirou ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Arterioclerosis obliterans; High shear stress; Interleukin 6; Platelet derived microparticles; Thrombopoietin

Indexed keywords

ANTITHROMBOCYTIC AGENT; CD63 ANTIGEN; CILOSTAZOL; CYTOKINE; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 3; INTERLEUKIN 6; PADGEM PROTEIN; PROCOAGULANT; STEM CELL FACTOR; THROMBOMODULIN; THROMBOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BLOOD VESSEL GRAFT; BYPASS SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MICROTHROMBUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SHEAR STRESS;

AGED; ARTERIOSCLEROSIS OBLITERANS; BIOLOGICAL MARKERS; BLOOD PLATELETS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CELL ADHESION MOLECULES; COMBINED MODALITY THERAPY; CYTOKINES; DIABETES COMPLICATIONS; FEMALE; FEMORAL ARTERY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMORHEOLOGY; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; ILIAC ARTERY; INTERLEUKIN-1; INTERLEUKIN-6; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; POPLITEAL ARTERY; POSTOPERATIVE PERIOD; STRESS, MECHANICAL; TETRAZOLES; THROMBOPOIETIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034657057     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00186-9     Document Type: Article

References (63)

1. Williams K.J., Tabas I. The response-to-retention hypothesis of early atherogenesis. Arteriosclerosis Thromb Vascular Biol. 15:1995;551-561.
2. Schwartz S.M., deBlois D., O'Brien E.R. The intima. Soil for atherosclerosis and restenosis. Circ Res. 77:1995;445-465.
3. Ross R. The pathogenesis of atherosclerosis. N Engl J Med. 314:1986;488-500.
4. Freeman M.B., Sicard G.A., Valentin L.I., Neuberger S., Mangino M.J., Anderson C.B. The association of in vitro arachidonic acid responsiveness and plasma thromboxane levels with early platelet deposition on the luminal surface of small-diameter grafts. J Vasc Surg. 7:1988;554-561.
5. Cronenwett J.L., Shapiro D.V., Luce J.L. Effect of prolonged intra-arterial prostaglandin E1 infusion on canine arterial graft patency. Arch Surg. 121:1986;760-764.
6. Ohzato H., Yoshizaki K., Nishimoto N., Ogata A., Tagoh H., Monden M., Gotoh M., Kishimoto T., Mori T. Interleukin-6 as a new indicator of inflammatory status. Detection of serum levels of interleukin-6 and C-reactive protein after surgery Surgery. 111:1990;201-209.
7. Krause T.J., Robertson F.M., Liesch J.B., Wasserman A.J., Greco R.S. Differential production of interleukin 1 on the surface of biomaterials. Arch Surg. 125:1990;1158-1160.
8. Margiotta M.S., Robertson F.S., Greco R.S. The adherence of endothelial cells to Dacron induces the expression of the intracellular adhesion molecule (ICAM-1). Ann Surg. 216:1992;600-604.
9. Dinarello C.A., Cannon J.G., Wolff S.M., Bernheim M.A., Beutler B., Cerami A., Figari I.S., Palladino M.A. Jr., O'Connor J.V. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med. 163:1986;1433-1450.
10. Heinrich P.C., Castell J.V., Andus T. Interleukin-6 and the acute phase response. Biochem J. 265:1990;621-636.
11. Kushner I. Regulation of the acute phase response by cytokines. Perspect Biol Med. 36:1993;611-622.
12. Parsson H.N., Nassberger L., Norgren L. Inflammatory response to aorto-bifemoral graft surgery. Int Angiol. 16:1997;55-64.
13. Shimoda K., Okamura S., Harada N., Kondo S., Okamura T., Niho Y. Identification of a functional receptor for granulocyte colony-stimulating factor on platelets. J Clin Invest. 91:1993;1310-1313.
14. Grabarek J., Groopman J.E., Lyles Y.R., Jiang S., Bennett L., Zsebo K., Avraham H. Human kit ligand (stem cell factor) modulates platelet activation in vitro. J Biol Chem. 269:1994;21718-21724.
15. Oleksowicz L., Mrowiec Z., Zuckerman D., Isaacs R., Dutcher J., Puszkin E. Platelet activation induced by interleukin-6. Evidence for a mechanism involving arachidonic acid metabolism Thromb Haemost. 72:1994;302-308.
16. Oleksowicz L., Mrowiec Z., Isaacs R., Dutcher J.P., Puszkin E. Morphologic and ultrastructual evidence for interleukin-6 induced platelet activation. Am J Hematol. 48:1995;92-99.
17. Chen J., Herceg-Harjacek L., Groopman J.E., Grabarek J. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. Blood. 86:1995;4054-4062.
18. Ezumi Y., Takayama H., Okuma M. Thrombopoietin, c-Mpl ligand, induces tyrosine phosphorylation of Tyk2, JAK2, and STAT3, and enhances agonists-induced aggregation in platelets in vitro. FEBS Lett. 374:1995;48-52.
19. Kojima H., Hamazaki Y., Nagata Y., Tadokoro K., Nagasawa T. Modulation of platelet activation in vitro by thrombopoietin. Thromb Haemost. 74:1995;1541-1545.
20. Oda A., Miyakawa Y., Druker B.J., Ozaki K., Yabusaki K., Shirasawa Y., Handa M., Kato T., Miyazaki H., Shimosaka A., Ikeda Y. Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists. Blood. 87:1996;4664-4670.
21. Rodriguez-Linares B., Watson S.P. Thrombopoietin potentiates activation of human platelets in association with JAK2 and TYK2 phosphorylation. Biochem J. 316:1996;93-98.
22. Wun T., Paglieroni T., Hammond W.P., Kaushansky K., Foster D.C. Thrombo-poietin is synergistic with other hematopoietic growth factors and physiologic platelet agonists for platelet activation in vitro. Am J Hematol. 54:1997;225-232.
23. Sims P.J., Wiedmer T., Esmon C.T., Weiss H.J., Shattil S.J. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. J Biol Chem. 264:1989;17049-17057.
24. Moake J.L., Turner N.A., Stathopoulos N.A., Nolasco L.H., Hellums J.D. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest. 78:1986;1456-1461.
25. O'Brien J.R. Shear-induced platelet aggregation. Lancet. 335:1990;711-713.
26. Ikeda Y., Handa M., Kawano K., Kamata T., Murata M., Araki Y., Anbo H., Kawai Y., Watanabe K., Itagaki I., Sakai K., Ruggeri Z.M. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest. 87:1991;1234-1240.
27. Ruggeri Z.M. Mechanisms of shear-induced platelet aggregation. Thromb Haemost. 70:1993;119-123.
28. Butler J. Shear stress platelet activation. Lancet. 346:1995;841.
29. Miyazaki Y., Nomura S., Miyake T., Kagawa H., Kitada C., Taniguchi H., Komiyama Y., Fujimura Y., Ikeda Y., Fukuhara S. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood. 88:1996;3456-3464.
30. Nomura S., Suzuki M., Kido H., Yamaguchi K., Fukuroi T., Yanabu M., Soga T., Nagata H., Kokawa T., Yasunaga K. Differences between platelet and microparticle glycoprotein IIb/IIIa. Cytometry. 13:1992;621-629.
31. Nomura S., Komiyama Y., Miyake T., Miyazaki Y., Kido H., Suzuki M., Kagawa H., Yanabu M., Takahashi H., Fukuhara S. Amyloid β-protein precursor-rich platelet microparticles in thrombotic disease. Thromb Haemost. 72:1994;519-522.
32. Nomura S., Suzuki M., Katsura K., Xie G.L., Miyazaki Y., Miyake T., Kido H., Kagawa H., Fukuhara S. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis. 116:1995;235-240.
33. Miyake T., Nomura S., Komiyama Y., Miyazaki Y., Kagawa H., Masuda M., Takahashi H., Fujimura Y., Ikeda Y., Fukuhara S. Effect of a new monoclonal anti-glycoprotein IX antibody, KMP-9, on high shear-induced platelet aggregation. Thromb Haemost. 78:1997;902-909.
34. Nomura S., Nagata H., Oda K., Kokawa T., Yasunaga K. Effects of EDTA on the membrane glycoproteins IIb-IIIa complex - Analysis using flow cytometry. Thromb Res. 47:1987;47-58.
35. Yanabu M., Ozaki Y., Nomura S., Miyake T., Miyazaki Y., Kagawa H., Yamanaka Y., Asazuma N., Satoh K., Kume S., Komiyama Y., Fukuhara S. Tyrosine phosphorylation and p72syk activation by an anti-glycoprotein Ib monoclonal antibody. Blood. 89:1997;1590-1598.
36. Ikeda Y., Handa M., Kamata T., Kawana K., Kawai Y., Watanabe K., Kawakami K., Sakai K., Fukuyama M., Itagaki I., Yoshioka A., Ruggeri Z.M. Transmembrane calcium influx associated with von Willebrand factor binding to GPIb in the initiation of shear-induced platelet aggregation. Thromb Haemost. 69:1993;496-502.
37. Zwaal R.F.A., Comfurius P., Bevers E.M. Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis Biochim Biophys Acta. 1180:1992;1-8.
38. Tans G., Rosing J., Thomassen M.C., Heeb M.J., Zwaal R.F.A., Griffin J.H. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood. 77:1991;2641-2648.
39. Dahlback B., Wiedmer T., Sims P.J. Binding of anticoagulant vitamin K-dependent protein S to platelet-derived microparticles. Biochemistry. 31:1992;12769-12777.
40. Gilbert G.E., Sims P.J., Wiedmer T., Furie B., Furie B.C., Shattil S.J. Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem. 266:1991;17261-17268.
41. Comfurius P., Senden J.M.G., Tilly R.H.J., Schroit A.J., Bevers E.M., Zwaal R.F.A. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of amminophospholipid translocase. Biochim Biophys Acta. 1026:1990;153-160.
42. George J.N., Pickett E.B., Saucerman S., McEver R.P., Kunicki T.J., Kieffer N., Newman P.J. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery J Clin Invest. 78:1986;340-348.
43. Abrams C.S., Ellison N., Budzynski A.Z., Shattil S.J. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood. 75:1990;128-138.
44. Nieuwland R., Berckmans R.J., Rotteveel-Eijkman R.C., Maquelin K.N., Roozendaal K.J., Jansen P.G.M., ten Have K., Eijsman L., Hack C.E., Sturk A. Cell-derived microparticles generated in patients during cardio-pulmonary bypass are highly procoagulant. Circulation. 96:1997;3534-3541.
45. Gawaz M., Neumann F.-J., Ott I., Schiessler A., Schomig A. Platelet function in acute myocardial infarction treated with direct angioplasty. Circulation. 93:1996;229-237.
46. Katopodis J.N., Kolodny L., Jy W., Horstman L.L., De Marchena E.J., Tao J.G., Haynes D.H., Ahn Y.S. Platelet microparticles and calcium homeostasis in acute coronary ischemias. Am J Hematol. 54:1997;95-101.
47. Nomura S., Shouzu A., Omoto S., Hayakawa T., Kagawa H., Nishikawa M., Inada M., Fujimura Y., Ikeda Y., Fukuhara S. Effect of cilostazol on soluble adhesion molecules and platelet-derived microparticles in patients with diabetes. Thromb Haemost. 80:1998;388-392.
48. Omoto S., Nomura S., Shouzu A., Hayakawa T., Shimizu H., Miyake Y., Yonemoto T., Nishikawa M., Fukuhara S., Inada M. Significance of platelet-derived microparticles and activated platelets in diabetic nephropathy. Nephron. 81:1999;271-277.
49. Warkentin E.T., Hayward C.P.M., Boshkov L.K., Santos A.V., Sheppard J.A.I., Bode A.P., Kelton J.G. Sera from patients with heparin-induced thrombo-cytopenia generate platelet-derived microparticles with procoagulant activity. An explanation for the thrombotic complications of heparin-induced thrombocytopenia Blood. 84:1994;3691-3699.
50. Kelton J.G., Warkentin T.E., Hayward C.P.M., Murphy W.G., Moore J.C. Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles. Blood. 80:1992;2246-2251.
51. Lee Y.J., Jy W., Horstman L.L., Janania J., Reyes Y., Kelley R.E., Ahn Y.S. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. Thromb Res. 72:1996;295-304.
52. Tschoepe D., Driesch E., Schwippert B., Nieuwenhuis H.K., Gries F.A. Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia. Diabetes. 44:1995;890-894.
53. Tschoepe D., Driesch E., Schwippert B., Lampeter E.F. Activated platelets in subjects at increased risk of IDDM. DENIS Study Group. Deutsche Nikotinamid Interventions studies. Diabetologia. 40:1997;573-577.
54. Sims P.J., Faioni E.M., Wiedmer T., Shattil S.J. Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem. 263:1988;18205-18212.
55. Van Snick J. Interleukin 6. An overview Annu Rev Immunol. 8:1990;253-278.
56. Neumann F.J., Ott I., Gawaz M., Richardt G., Jochum M., Holzapfel H., Schomig A. Cardiac release of cytokines and inflammatory responses during reperfusion in acute myocardial infarction. Circulation. 92:1995;748-755.
57. Peng J., Friese P., George J.N., Dale G.L., Burnstein S.A. Alteration of platelet function in dogs mediated by interleukin-6. Blood. 83:1994;398-403.
58. Kaushansky K. Thrombopoietin. The primary regulator of platelet production Blood. 86:1995;419-431.
59. Miyakawa Y., Oda A., Druker B.J. Recombinant thrombopoietin induces rapid protein tyrosine phosphorylation of Janus kinase 2 and Shc in human blood platelets. Blood. 86:1995;23-27.
60. Holme P.A., Orvim U., Hamers M.J.A.G., Solum N.O., Brosstad E.R., Barstad R.M., Sakariassen K.S. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol. 17:1997;646-653.
61. Umekawa H., Tanaka T., Kimura Y., Hidaka H. Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new-inhibitor sepharose chromatography. Biochem Pharmacol. 33:1984;3339-3344.
62. Minami N., Suzuki Y., Yamamoto M., Kihira H., Imai E., Wada H., Kimura Y., Ikeda Y., Shiku H., Nishikawa M. Inhibition of shear stress-induced platelet aggregation by cilostazol, a specific inhibitor of cGMP-inhibited phosphodiesterase, in vitro and ex vivo. Life Sci. 61:1997;PL383-PL389.
63. Barry O.P., Pratico D., Lawson J.A., FitzGerald G.A. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest. 99:1997;2118-2127.